Lingfei Xu
- Genetics top 5%
- Molecular Biology
- Physiology top 10%
- Oncology
- Epidemiology
- Co-authors
- Katherine P. PonderMark E. HaskinsMark S. SandsCuihua GaoN. Matthew EllinwoodDwight A. BellingerTimothy C. NicholsSihong Song
- Topics
- Virus-based gene therapy research (12 papers)RNA Interference and Gene Delivery (5 papers)Adenosine and Purinergic Signaling (4 papers)
- Cited by
- GeneticsPhysiology
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Lingfei Xu
17 papers receiving 742 citations
Peers
Comparison fields: 5 of 62
- Genetics 466
- Molecular Biology 393
- Physiology 238
- Oncology 132
- Epidemiology 121
Countries citing papers authored by Lingfei Xu
This map shows the geographic impact of Lingfei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfei Xu more than expected).
Fields of papers citing papers by Lingfei Xu
This network shows the impact of papers produced by Lingfei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfei Xu. The network helps show where Lingfei Xu may publish in the future.
Co-authorship network of co-authors of Lingfei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Lingfei Xu. A scholar is included among the top collaborators of Lingfei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfei Xu. Lingfei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 10 | |
| 3 | 32 | |
| 4 | 33 | |
| 5 | 62 | |
| 6 | 18 | |
| 7 | 73 | |
| 8 | 1 | |
| 9 | Long term gene therapy of Parkinson's disease using immortalized rat glial cell line with tyrosine hydroxylase gene. | 3 |
| 10 | 13 | |
| 11 | 82 | |
| 12 | 41 | |
| 13 | 57 | |
| 14 | 59 | |
| 15 | 132 | |
| 16 | 144 | |
| 17 | Treatment of Parkinson's Disease by Genetically Modified Immortalized Fibroblasts. | 1 |
About Lingfei Xu
Lingfei Xu is a scholar working on Physiology, Genetics and Genetics, having authored 17 papers that have together received 764 indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), RNA Interference and Gene Delivery (5 papers) and Adenosine and Purinergic Signaling (4 papers). The work is most often cited by research in Genetics (466 citations), Physiology (42 citations) and Physiology (238 citations). Lingfei Xu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Katherine P. Ponder, Mark E. Haskins, Mark S. Sands, Cuihua Gao, N. Matthew Ellinwood, Dwight A. Bellinger, Timothy C. Nichols, Sihong Song, Terence R. Flotte and Barry J. Byrne. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.